Top Markets
Coin of the day
Elevation Oncology, Inc. Elevation Oncology, Inc.

Elevation Oncology, Inc.

ELEV
Rangering i aksjer #29358
Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company... Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company operating in the United States, committed to developing targeted cancer therapies for patients with specific genetic profiles. Its leading drug candidate is seribantumab, an anti-HER3 monoclonal antibody currently being evaluated in the Phase II CRESTONE trial. This study focuses on treating advanced solid tumors that harbor a neuregulin-1 fusion. The company was established in 2019 and is headquartered in New York, New York.
Aksjekurs
$0.365
Sist synkronisert: 2025-08-01
Markedsverdi
$21.54M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Elevation Oncology, Inc. (ELEV)

Kategori

Historikk for aksjesplitt for Elevation Oncology, Inc. (ELEV)
Aksjen Elevation Oncology, Inc. (symbol: ELEV) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 19, 2026.
Én ELEV-aksje kjøpt før Aug 19, 2026 tilsvarer i dag 0 ELEV-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH